Healthcare Triangle, Inc.
NASDAQ:HCTI
0.853 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2.413 | 2.984 | 4.109 | 7.06 | 7.779 | 8.526 | 9.838 | 11.292 | 11.95 | 11.588 | 11.056 | 9.189 | 8.078 | 10.05 | 7.953 | 8.995 | 7.361 | 7.557 | 7.427 |
Cost of Revenue
| 1.691 | 2.086 | 3.631 | 5.53 | 6.072 | 6.579 | 8.245 | 9.478 | 8.522 | 8.429 | 8.162 | 6.92 | 5.352 | 6.704 | 5.773 | 6.59 | 5.359 | 5.551 | 5.254 |
Gross Profit
| 0.722 | 0.898 | 0.478 | 1.53 | 1.707 | 1.947 | 1.593 | 1.814 | 3.428 | 3.159 | 2.894 | 2.269 | 2.727 | 3.345 | 2.18 | 2.405 | 2.002 | 2.006 | 2.173 |
Gross Profit Ratio
| 0.299 | 0.301 | 0.116 | 0.217 | 0.219 | 0.228 | 0.162 | 0.161 | 0.287 | 0.273 | 0.262 | 0.247 | 0.338 | 0.333 | 0.274 | 0.267 | 0.272 | 0.265 | 0.293 |
Reseach & Development Expenses
| 0.175 | 0.207 | 0.127 | 0.104 | 0.054 | 0.102 | 0.539 | 2.77 | 1.471 | 0.646 | 1.066 | 1.483 | 2.204 | 0.813 | 0.757 | 0.274 | 0.55 | 0.492 | 0.427 |
General & Administrative Expenses
| 1.077 | 0.904 | 1.176 | 0.82 | 1.364 | 1.612 | 1.628 | 1.293 | 1.48 | 1.451 | 1.351 | 1.379 | 0.753 | 1.048 | 1.26 | 0.112 | 0.583 | 0.911 | 0.878 |
Selling & Marketing Expenses
| 0.294 | 0.631 | 0.883 | 0.782 | 1.101 | 1.026 | 1.761 | 1.602 | 1.815 | 1.651 | 1.74 | 1.96 | 1.328 | 0.805 | 0.668 | 1.321 | 0.477 | 0.261 | 0.336 |
SG&A
| 1.371 | 1.535 | 2.059 | 1.602 | 2.465 | 2.638 | 3.389 | 2.895 | 3.295 | 3.102 | 3.091 | 3.338 | 2.082 | 1.853 | 1.928 | 1.433 | 1.06 | 1.172 | 1.269 |
Other Expenses
| 0 | 0.534 | 0.127 | 4.844 | 0.712 | 0.802 | 0.874 | 0.91 | 0.909 | 0.844 | 0.711 | -0.201 | 0 | 0.211 | 0.211 | 0.2 | 0.201 | 0.202 | 0 |
Operating Expenses
| 1.546 | 1.742 | 2.186 | 6.55 | 3.231 | 3.542 | 4.802 | 6.575 | 5.675 | 4.592 | 4.868 | 5.609 | 4.497 | 2.878 | 2.896 | 1.906 | 1.811 | 1.866 | 1.826 |
Operating Income
| -1.167 | -1.378 | -1.708 | -5.02 | -1.524 | -1.595 | -3.209 | -4.762 | -2.247 | -1.433 | -1.974 | -6.684 | -1.77 | 0.468 | -0.716 | 0.498 | 0.191 | 0.14 | 0.277 |
Operating Income Ratio
| -0.484 | -0.462 | -0.416 | -0.711 | -0.196 | -0.187 | -0.326 | -0.422 | -0.188 | -0.124 | -0.179 | -0.727 | -0.219 | 0.047 | -0.09 | 0.055 | 0.026 | 0.019 | 0.037 |
Total Other Income Expenses Net
| -0.08 | -0.131 | -0.149 | -0.305 | -0.415 | -0.186 | -0.05 | -0.089 | -0.055 | 1.029 | -0.016 | -0.088 | -0.221 | -0.164 | -0.095 | 0.781 | -0.001 | -0.006 | -0.149 |
Income Before Tax
| -1.247 | -1.509 | -1.857 | -5.325 | -1.939 | -1.781 | -3.259 | -4.851 | -2.302 | -0.404 | -1.99 | -3.427 | -1.991 | 0.303 | -0.811 | 1.957 | 0.19 | 0.135 | 0.329 |
Income Before Tax Ratio
| -0.517 | -0.506 | -0.452 | -0.754 | -0.249 | -0.209 | -0.331 | -0.43 | -0.193 | -0.035 | -0.18 | -0.373 | -0.246 | 0.03 | -0.102 | 0.218 | 0.026 | 0.018 | 0.044 |
Income Tax Expense
| 0.002 | 0.001 | 0.005 | 0.007 | 0.004 | 0.005 | 0.019 | 0.012 | 0.037 | 0.001 | 0.021 | 0.019 | 0.001 | 0.001 | 0.003 | 0.081 | 0.051 | 0.037 | 0.089 |
Net Income
| -1.249 | -1.51 | -1.862 | -5.332 | -1.943 | -1.786 | -3.278 | -4.863 | -2.339 | -0.405 | -2.011 | -3.447 | -1.992 | 0.304 | -0.814 | 1.876 | 0.139 | 0.098 | 0.24 |
Net Income Ratio
| -0.518 | -0.506 | -0.453 | -0.755 | -0.25 | -0.209 | -0.333 | -0.431 | -0.196 | -0.035 | -0.182 | -0.375 | -0.247 | 0.03 | -0.102 | 0.209 | 0.019 | 0.013 | 0.032 |
EPS
| -0.22 | -0.28 | -0.42 | -1.24 | -0.46 | -0.42 | -0.78 | -1.17 | -0.65 | -0.11 | -0.57 | -1.1 | -0.7 | 0.1 | -0.28 | 0.67 | 0.05 | 0.028 | 0.069 |
EPS Diluted
| -0.22 | -0.28 | -0.42 | -1.24 | -0.46 | -0.42 | -0.78 | -1.17 | -0.65 | -0.11 | -0.57 | -1.1 | -0.69 | 0.1 | -0.28 | 0.67 | 0.05 | 0.028 | 0.069 |
EBITDA
| -0.824 | -0.844 | -1.172 | -0.176 | -0.812 | -0.793 | -2.323 | -3.858 | -1.338 | 0.498 | -1.263 | -2.552 | -1.559 | 0.679 | -0.505 | 0.698 | 0.392 | 0.342 | 0.478 |
EBITDA Ratio
| -0.341 | -0.283 | -0.285 | -0.025 | -0.104 | -0.093 | -0.237 | -0.341 | -0.112 | -0.051 | -0.114 | -0.278 | -0.193 | 0.068 | -0.063 | 0.078 | 0.053 | 0.045 | 0.064 |